Optipharm.CO.,LTD (KOSDAQ:153710)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,210.00
+60.00 (1.17%)
At close: Apr 28, 2026
-1.14%
Market Cap 76.43B
Revenue (ttm) 22.34B
Net Income (ttm) -2.50B
Shares Out 14.67M
EPS (ttm) -170.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,935
Average Volume 31,026
Open 5,110.00
Previous Close 5,150.00
Day's Range 5,060.00 - 5,260.00
52-Week Range 4,725.00 - 6,250.00
Beta 0.03
RSI 49.58
Earnings Date n/a

About Optipharm.CO.,LTD

Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and changed its name to Optipharm.CO.,LTD in 2012. Optipharm.CO.,LTD was founded in 2000 and is based in Cheongju, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 153710
Full Company Profile

Financial Performance

In 2025, Optipharm.CO.,LTD's revenue was 22.34 billion, an increase of 13.79% compared to the previous year's 19.64 billion. Losses were -2.50 billion, 6.05% more than in 2024.

Financial Statements

News

There is no news available yet.